Cara Therapeutics, Inc.
USD5.32
-0.14 (-2.56%)
CEO
Christopher A. Posner
IPO Date
2014-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.80
Prev. Close
$5.46
Day Low
$5.28
Day High
$5.52
52W Low
$5.28
52W High
$31.32
Market Cap
$0.01B
Volume
0.24M
| -0.1 |
| 31 Dec 2023 | FY | 69.3% | -565.2% | 191.0% | -438.9% | -0.01 | 7.97 | -0.4 |
| 31 Dec 2022 | FY | 82.1% | -204.2% | 189.7% | -189.5% | -0.05 | 10.31 | -0.5 |
| 31 Dec 2021 | FY | 93.3% | -384.1% | -38.9% | -35.8% | 0.02 | 9.84 | -0.1 |
| 31 Dec 2020 | FY | 0.0% | 6.2% | 3.4% | 3.1% | 0.02 | 10.55 | 0.8 |
| -1.4 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -19.8% | -14.2% | 0.01 | 3.48 | -16.5 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 12.7% | 9.5% | 0.01 | 4.04 | 11.5 |
| 31 Mar 2025 | Q1 | 100.0% | -191.0% | 32.4% | -17.6% | -2.38 | 3.35 | -2.3 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | 276.7% | -29.0% | -9.68 | 11.03 | -0.1 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -779.8% | -10.7% | 62.23 | 4.77 | -0.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -60.1% | -9.6% | 4.07 | 4.59 | -0.3 |
| 31 Mar 2024 | Q1 | 71.0% | -1437.8% | -103.0% | -34.1% | 1.52 | 5.38 | -0.4 |
| 31 Dec 2023 | Q4 | 77.0% | -1076.5% | 52.1% | -119.8% | -0.01 | 7.97 | -0.4 |